| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Proximal | 8 | 2022 | 18 | 2.680 |
Why?
|
| Models, Biological | 6 | 2024 | 1143 | 1.570 |
Why?
|
| Kidney Diseases | 4 | 2022 | 169 | 1.550 |
Why?
|
| Corneal Dystrophies, Hereditary | 3 | 2017 | 3 | 1.120 |
Why?
|
| Liver | 11 | 2020 | 796 | 1.080 |
Why?
|
| Retinal Diseases | 3 | 2017 | 31 | 1.070 |
Why?
|
| Plasma | 2 | 2024 | 35 | 1.020 |
Why?
|
| Cytochrome P-450 CYP3A | 4 | 2024 | 10 | 0.980 |
Why?
|
| Trauma Centers | 6 | 2022 | 114 | 0.950 |
Why?
|
| Syndecan-1 | 1 | 2024 | 7 | 0.910 |
Why?
|
| Kidney | 7 | 2020 | 414 | 0.900 |
Why?
|
| Burns | 1 | 2024 | 41 | 0.880 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2024 | 574 | 0.870 |
Why?
|
| Resuscitation | 1 | 2024 | 70 | 0.860 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2021 | 89 | 0.770 |
Why?
|
| Epithelial Cells | 4 | 2020 | 391 | 0.750 |
Why?
|
| Prescription Drugs | 1 | 2021 | 47 | 0.720 |
Why?
|
| Drug Discovery | 2 | 2021 | 89 | 0.710 |
Why?
|
| Ochratoxins | 1 | 2020 | 1 | 0.710 |
Why?
|
| Toxicity Tests | 2 | 2017 | 17 | 0.690 |
Why?
|
| Cytochrome P450 Family 4 | 3 | 2017 | 3 | 0.680 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2021 | 137 | 0.650 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2051 | 0.620 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2020 | 26 | 0.590 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 31 | 0.550 |
Why?
|
| Renal Elimination | 1 | 2016 | 3 | 0.540 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 483 | 0.530 |
Why?
|
| General Surgery | 3 | 2016 | 191 | 0.530 |
Why?
|
| Forecasting | 1 | 2017 | 221 | 0.520 |
Why?
|
| Biological Transport | 6 | 2024 | 288 | 0.480 |
Why?
|
| Traumatology | 2 | 2016 | 8 | 0.430 |
Why?
|
| Mutation | 2 | 2021 | 2458 | 0.420 |
Why?
|
| DNA | 2 | 2017 | 805 | 0.410 |
Why?
|
| Space Flight | 2 | 2022 | 17 | 0.400 |
Why?
|
| Humans | 48 | 2024 | 59424 | 0.390 |
Why?
|
| Ichthyosis, Lamellar | 1 | 2011 | 1 | 0.370 |
Why?
|
| Cell Line | 5 | 2021 | 1984 | 0.340 |
Why?
|
| Wounds and Injuries | 3 | 2018 | 229 | 0.340 |
Why?
|
| Emergency Medicine | 1 | 2012 | 182 | 0.330 |
Why?
|
| Education, Medical, Graduate | 1 | 2012 | 317 | 0.320 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 81 | 0.290 |
Why?
|
| Cell Culture Techniques | 3 | 2020 | 178 | 0.290 |
Why?
|
| Intestinal Absorption | 2 | 2024 | 29 | 0.280 |
Why?
|
| Cytochrome P-450 CYP2D6 | 3 | 2016 | 5 | 0.280 |
Why?
|
| Emergencies | 3 | 2019 | 110 | 0.270 |
Why?
|
| Organic Anion Transporters | 2 | 2023 | 5 | 0.250 |
Why?
|
| Rats | 4 | 2024 | 1911 | 0.250 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 123 | 0.250 |
Why?
|
| Enterocytes | 1 | 2024 | 24 | 0.230 |
Why?
|
| Organoids | 1 | 2024 | 40 | 0.230 |
Why?
|
| Glycocalyx | 1 | 2024 | 3 | 0.230 |
Why?
|
| Animals | 14 | 2024 | 19664 | 0.230 |
Why?
|
| Shock | 1 | 2024 | 31 | 0.230 |
Why?
|
| Pharmaceutical Preparations | 3 | 2024 | 117 | 0.220 |
Why?
|
| RNA, Messenger | 5 | 2016 | 1469 | 0.210 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 169 | 0.210 |
Why?
|
| Male | 20 | 2024 | 27772 | 0.200 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 227 | 0.200 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 35 | 0.200 |
Why?
|
| Weightlessness | 1 | 2022 | 11 | 0.200 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2021 | 114 | 0.200 |
Why?
|
| Pilots | 1 | 2022 | 9 | 0.200 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2022 | 16 | 0.200 |
Why?
|
| Computer Simulation | 2 | 2022 | 459 | 0.200 |
Why?
|
| Hospitals, Community | 1 | 2022 | 70 | 0.200 |
Why?
|
| Air Ambulances | 1 | 2022 | 26 | 0.200 |
Why?
|
| Hepatitis C | 2 | 2016 | 143 | 0.200 |
Why?
|
| Female | 22 | 2022 | 30753 | 0.190 |
Why?
|
| Appendicitis | 1 | 2022 | 74 | 0.190 |
Why?
|
| Xenobiotics | 2 | 2018 | 13 | 0.190 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2021 | 38 | 0.190 |
Why?
|
| G-Quadruplexes | 1 | 2021 | 6 | 0.180 |
Why?
|
| Postoperative Complications | 3 | 2022 | 1204 | 0.180 |
Why?
|
| Morpholinos | 1 | 2021 | 50 | 0.180 |
Why?
|
| Aldehyde Oxidase | 1 | 2020 | 1 | 0.180 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 11 | 0.180 |
Why?
|
| Pregnancy | 4 | 2019 | 2214 | 0.180 |
Why?
|
| Sulfotransferases | 1 | 2020 | 8 | 0.180 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2020 | 11 | 0.180 |
Why?
|
| Hepatocytes | 3 | 2017 | 196 | 0.180 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 20 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2016 | 850 | 0.180 |
Why?
|
| Organic Cation Transport Proteins | 3 | 2020 | 3 | 0.180 |
Why?
|
| Middle Aged | 13 | 2022 | 16330 | 0.180 |
Why?
|
| Intestines | 1 | 2021 | 158 | 0.170 |
Why?
|
| Cisplatin | 1 | 2020 | 119 | 0.170 |
Why?
|
| Intestine, Small | 1 | 2020 | 77 | 0.170 |
Why?
|
| Drug Antagonism | 1 | 2019 | 9 | 0.170 |
Why?
|
| Surgeons | 1 | 2022 | 161 | 0.170 |
Why?
|
| Desogestrel | 1 | 2019 | 4 | 0.170 |
Why?
|
| Benzoxazines | 1 | 2019 | 10 | 0.170 |
Why?
|
| Levonorgestrel | 1 | 2019 | 10 | 0.170 |
Why?
|
| Iohexol | 1 | 2019 | 16 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 170 | 0.160 |
Why?
|
| Contraceptive Agents, Female | 1 | 2019 | 24 | 0.160 |
Why?
|
| Critical Pathways | 1 | 2019 | 32 | 0.160 |
Why?
|
| Digestive System Diseases | 1 | 2019 | 14 | 0.160 |
Why?
|
| Intestinal Obstruction | 1 | 2019 | 49 | 0.160 |
Why?
|
| Emergency Medical Services | 1 | 2022 | 256 | 0.160 |
Why?
|
| Microsomes | 2 | 2016 | 11 | 0.150 |
Why?
|
| HEK293 Cells | 1 | 2021 | 587 | 0.150 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 132 | 0.150 |
Why?
|
| Myocardium | 1 | 2020 | 264 | 0.150 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 805 | 0.150 |
Why?
|
| Hospital Mortality | 4 | 2016 | 845 | 0.150 |
Why?
|
| Hematologic Neoplasms | 1 | 2019 | 44 | 0.150 |
Why?
|
| Lymphoma | 1 | 2019 | 99 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2019 | 88 | 0.150 |
Why?
|
| Anti-HIV Agents | 1 | 2019 | 153 | 0.150 |
Why?
|
| Aristolochic Acids | 1 | 2017 | 1 | 0.150 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 54 | 0.150 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 105 | 0.150 |
Why?
|
| Lung | 2 | 2020 | 920 | 0.140 |
Why?
|
| Fundus Oculi | 1 | 2017 | 21 | 0.140 |
Why?
|
| Hydrocortisone | 1 | 2019 | 187 | 0.140 |
Why?
|
| Electroretinography | 1 | 2017 | 26 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 495 | 0.140 |
Why?
|
| Genes, Recessive | 1 | 2017 | 49 | 0.140 |
Why?
|
| Referral and Consultation | 2 | 2022 | 405 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 114 | 0.140 |
Why?
|
| Fluorescein Angiography | 1 | 2017 | 57 | 0.140 |
Why?
|
| Vitamin D | 1 | 2018 | 132 | 0.140 |
Why?
|
| Pedigree | 1 | 2017 | 183 | 0.140 |
Why?
|
| Contrast Media | 1 | 2019 | 403 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 188 | 0.130 |
Why?
|
| Kidney Cortex | 1 | 2016 | 10 | 0.130 |
Why?
|
| Aged | 12 | 2022 | 13423 | 0.130 |
Why?
|
| Glucuronides | 1 | 2016 | 11 | 0.130 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 37 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2017 | 88 | 0.130 |
Why?
|
| Visual Acuity | 1 | 2017 | 117 | 0.130 |
Why?
|
| Terpenes | 1 | 2016 | 25 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2022 | 6077 | 0.130 |
Why?
|
| Hospitals, Low-Volume | 1 | 2016 | 17 | 0.130 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 328 | 0.130 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 167 | 0.130 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 57 | 0.130 |
Why?
|
| Health Services for the Aged | 1 | 2016 | 47 | 0.130 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 32 | 0.130 |
Why?
|
| Homeostasis | 1 | 2018 | 346 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2024 | 2095 | 0.120 |
Why?
|
| Heme Oxygenase-1 | 1 | 2015 | 18 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2016 | 84 | 0.120 |
Why?
|
| Proteome | 1 | 2016 | 141 | 0.120 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 72 | 0.120 |
Why?
|
| United States | 4 | 2022 | 7429 | 0.120 |
Why?
|
| State Government | 1 | 2015 | 29 | 0.120 |
Why?
|
| Internship and Residency | 1 | 2022 | 747 | 0.120 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 159 | 0.120 |
Why?
|
| Surgical Procedures, Operative | 2 | 2015 | 137 | 0.120 |
Why?
|
| Glyburide | 1 | 2014 | 4 | 0.120 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2014 | 10 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 276 | 0.120 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2338 | 0.120 |
Why?
|
| Liver Cirrhosis | 1 | 2016 | 163 | 0.120 |
Why?
|
| Morbidity | 1 | 2015 | 113 | 0.120 |
Why?
|
| Venous Thromboembolism | 1 | 2016 | 145 | 0.120 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2016 | 84 | 0.120 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2014 | 41 | 0.120 |
Why?
|
| Cell Survival | 1 | 2016 | 559 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 168 | 0.110 |
Why?
|
| Adult | 11 | 2020 | 15693 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2016 | 487 | 0.110 |
Why?
|
| Substrate Specificity | 2 | 2012 | 333 | 0.110 |
Why?
|
| Phenotype | 1 | 2017 | 1137 | 0.110 |
Why?
|
| Ethanol | 1 | 2016 | 306 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2014 | 584 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 3236 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 192 | 0.100 |
Why?
|
| Mice | 6 | 2023 | 10300 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 103 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 301 | 0.100 |
Why?
|
| Accreditation | 1 | 2012 | 73 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 652 | 0.090 |
Why?
|
| Cerebrospinal Fluid | 1 | 2011 | 19 | 0.090 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 98 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 5126 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 88 | 0.090 |
Why?
|
| Proteomics | 3 | 2017 | 263 | 0.090 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 203 | 0.090 |
Why?
|
| DNA, Viral | 1 | 2011 | 223 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2011 | 191 | 0.080 |
Why?
|
| Cytochrome P-450 CYP4A | 1 | 2009 | 1 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2022 | 526 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2022 | 915 | 0.080 |
Why?
|
| Metformin | 1 | 2010 | 64 | 0.080 |
Why?
|
| Diaphragmatic Eventration | 1 | 2008 | 2 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 128 | 0.080 |
Why?
|
| Adolescent | 5 | 2020 | 5842 | 0.080 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2008 | 9 | 0.080 |
Why?
|
| Length of Stay | 3 | 2019 | 779 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2017 | 12 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1206 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2008 | 124 | 0.070 |
Why?
|
| Organic Cation Transporter 2 | 2 | 2020 | 2 | 0.070 |
Why?
|
| Risk Factors | 4 | 2016 | 4990 | 0.060 |
Why?
|
| California | 2 | 2016 | 161 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 141 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2019 | 5285 | 0.060 |
Why?
|
| Nelfinavir | 1 | 2005 | 7 | 0.060 |
Why?
|
| Genes, MDR | 1 | 2005 | 3 | 0.060 |
Why?
|
| Dextrorphan | 2 | 2016 | 2 | 0.060 |
Why?
|
| Dextromethorphan | 2 | 2016 | 3 | 0.060 |
Why?
|
| Duodenum | 1 | 2024 | 42 | 0.060 |
Why?
|
| HIV Protease Inhibitors | 1 | 2005 | 105 | 0.060 |
Why?
|
| Fluorescein | 1 | 2023 | 13 | 0.050 |
Why?
|
| Anions | 1 | 2023 | 33 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2024 | 355 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2003 | 19 | 0.050 |
Why?
|
| RNA Precursors | 1 | 2004 | 74 | 0.050 |
Why?
|
| Young Adult | 3 | 2020 | 4273 | 0.050 |
Why?
|
| Spacecraft | 1 | 2022 | 6 | 0.050 |
Why?
|
| Splenectomy | 1 | 2022 | 41 | 0.050 |
Why?
|
| Rabbits | 2 | 2016 | 323 | 0.050 |
Why?
|
| Aircraft | 1 | 2022 | 18 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 529 | 0.050 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 80 | 0.050 |
Why?
|
| Appendectomy | 1 | 2022 | 49 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2022 | 18 | 0.050 |
Why?
|
| Proteinuria | 1 | 2022 | 38 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2022 | 75 | 0.050 |
Why?
|
| Cross Infection | 1 | 2003 | 152 | 0.050 |
Why?
|
| Fatigue | 1 | 2022 | 103 | 0.050 |
Why?
|
| Patient Readmission | 2 | 2016 | 421 | 0.050 |
Why?
|
| Kinetics | 1 | 2023 | 751 | 0.050 |
Why?
|
| Spleen | 1 | 2022 | 479 | 0.050 |
Why?
|
| Biomarkers | 2 | 2017 | 1306 | 0.050 |
Why?
|
| Cimetidine | 1 | 2020 | 3 | 0.040 |
Why?
|
| Biological Availability | 1 | 2021 | 195 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 3069 | 0.040 |
Why?
|
| Nevirapine | 1 | 2019 | 8 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2019 | 5 | 0.040 |
Why?
|
| Uganda | 1 | 2019 | 33 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2020 | 143 | 0.040 |
Why?
|
| Historically Controlled Study | 1 | 2019 | 1 | 0.040 |
Why?
|
| Alkynes | 1 | 2019 | 23 | 0.040 |
Why?
|
| Kenya | 1 | 2019 | 79 | 0.040 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 26 | 0.040 |
Why?
|
| Cyclopropanes | 1 | 2019 | 50 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 27 | 0.040 |
Why?
|
| Animal Testing Alternatives | 1 | 2018 | 1 | 0.040 |
Why?
|
| Linear Models | 1 | 2019 | 403 | 0.040 |
Why?
|
| Genotype | 2 | 2011 | 619 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 194 | 0.040 |
Why?
|
| Dicumarol | 1 | 2017 | 1 | 0.040 |
Why?
|
| Nephrons | 1 | 2017 | 7 | 0.040 |
Why?
|
| Biotransformation | 1 | 2017 | 23 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2017 | 10 | 0.040 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2017 | 41 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2019 | 365 | 0.040 |
Why?
|
| Carcinogens | 1 | 2017 | 37 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2022 | 683 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 36 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2017 | 126 | 0.030 |
Why?
|
| Endocytosis | 1 | 2018 | 149 | 0.030 |
Why?
|
| Child | 2 | 2020 | 4193 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 719 | 0.030 |
Why?
|
| Brain | 1 | 2005 | 1488 | 0.030 |
Why?
|
| Abbreviated Injury Scale | 1 | 2016 | 13 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2016 | 46 | 0.030 |
Why?
|
| Failure to Rescue, Health Care | 1 | 2016 | 4 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2016 | 115 | 0.030 |
Why?
|
| Geriatrics | 1 | 2016 | 41 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 329 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 304 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 303 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1794 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 104 | 0.030 |
Why?
|
| Boston | 1 | 2016 | 247 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 810 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 314 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2014 | 20 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1022 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2016 | 201 | 0.030 |
Why?
|
| Patient Admission | 1 | 2016 | 184 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 226 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2013 | 34 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 2013 | 27 | 0.030 |
Why?
|
| Health Services Research | 1 | 2015 | 266 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2013 | 71 | 0.030 |
Why?
|
| Placenta | 1 | 2013 | 55 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 858 | 0.030 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2012 | 3 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2012 | 4 | 0.030 |
Why?
|
| Cytochrome P450 Family 2 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Hydroxylation | 1 | 2012 | 9 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2012 | 44 | 0.030 |
Why?
|
| Gestational Age | 1 | 2013 | 179 | 0.030 |
Why?
|
| New England | 1 | 2013 | 267 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 1078 | 0.030 |
Why?
|
| Response Elements | 1 | 2012 | 43 | 0.030 |
Why?
|
| Incidence | 1 | 2016 | 1239 | 0.030 |
Why?
|
| HIV Infections | 1 | 2019 | 913 | 0.030 |
Why?
|
| Tretinoin | 1 | 2012 | 49 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2016 | 814 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2012 | 55 | 0.020 |
Why?
|
| Logistic Models | 1 | 2016 | 1235 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2016 | 430 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 222 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 1505 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 46 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 2011 | 7 | 0.020 |
Why?
|
| Lac Operon | 1 | 2011 | 26 | 0.020 |
Why?
|
| Choroid Plexus | 1 | 2011 | 16 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1555 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1953 | 0.020 |
Why?
|
| Integrases | 1 | 2011 | 36 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 183 | 0.020 |
Why?
|
| Pregnancy Trimesters | 1 | 2010 | 10 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 1 | 2010 | 47 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 881 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2010 | 70 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2011 | 140 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2009 | 4 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 141 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 128 | 0.020 |
Why?
|
| Spodoptera | 1 | 2009 | 27 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 354 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2009 | 26 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 15 | 0.020 |
Why?
|
| Amidines | 1 | 2009 | 19 | 0.020 |
Why?
|
| Retinal Degeneration | 1 | 2009 | 27 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2011 | 357 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 2008 | 46 | 0.020 |
Why?
|
| Milk, Human | 1 | 2010 | 88 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1926 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2010 | 187 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 691 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3620 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 1286 | 0.020 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2005 | 1 | 0.020 |
Why?
|
| Acridines | 1 | 2005 | 2 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2005 | 16 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2005 | 52 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2005 | 184 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 287 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 104 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2005 | 191 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2005 | 394 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 67 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 439 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1368 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2005 | 1997 | 0.010 |
Why?
|